首页> The Journal of clinical and aesthetic dermatology> Efficacy of Fixed-combination Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Foam for Scalp Plaque Psoriasis: Additional Analysis of a Phase II, Randomized Clinical Study.

Efficacy of Fixed-combination Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Foam for Scalp Plaque Psoriasis: Additional Analysis of a Phase II, Randomized Clinical Study.

导出 OA

翻译打印收藏纠错

第一作者： Dharm S,Patel

第一单位： Drs. Patel and Veverka are with LEO Pharma in Madison, New Jersey.;Dr. Hansen is with LEO Pharma in Ballerup, Denmark.;Dr. Yamauchi is with the Division of Dermatology at the David Geffen School of Medicine at UCLA in Los Angeles, California.;Dr. Alonso-Llamazares is with the Department of Dermatology at the VA Medical Center in Miami, Florida.;Dr. Lebwohl is with the Department of Dermatology at the Icahn School of Medicine at Mount Sinai in New York, New York.

作者： Dharm S,Patel ^[1] ; Karen A,Veverka ^[1] ; Jes B,Hansen ^[1] ; Paul S,Yamauchi ^[1] ; Javier,Alonso-Llamazares ^[1] ; Mark,Lebwohl ^[1]

作者单位： Drs. Patel and Veverka are with LEO Pharma in Madison, New Jersey.;Dr. Hansen is with LEO Pharma in Ballerup, Denmark.;Dr. Yamauchi is with the Division of Dermatology at the David Geffen School of Medicine at UCLA in Los Angeles, California.;Dr. Alonso-Llamazares is with the Department of Dermatology at the VA Medical Center in Miami, Florida.;Dr. Lebwohl is with the Department of Dermatology at the Icahn School of Medicine at Mount Sinai in New York, New York. ^[1]

关键词 Calcipotriene betamethasone dipropionate foam scalp psoriasis target lesion

PMID 32802249

发布时间 2020-09-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交